Glaucoma as neurodegeneration in the brain
Eye and Brain, ISSN: 1179-2744, Vol: 13, Page: 21-28
2021
- 48Citations
- 64Captures
- 1Mentions
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations48
- Citation Indexes48
- 48
- Captures64
- Readers64
- 64
- Mentions1
- News Mentions1
- 1
Most Recent News
Glaucoma as Neurodegeneration in the Brain.
Eye Brain. 2021;13:21-28. Epub 2021 Jan 18 Authors: Chan JW, Chan NC, Sadun AA PubMed: 33500674 Submit Comment
Review Description
Glaucoma, a group of diseases characterized by progressive optic nerve degeneration that results in irreversible blindness, can be considered a neurodegenerative disorder of both the eye and the brain. Increasing evidence from human and animal studies have shown that glaucoma shares some common neurodegenerative pathways with Alzheimer’s disease (AD) and other tauopathies, such as chronic traumatic encephalopathy (CTE) and frontotemporal dementia. This hypothesis is based on the focal adhesion pathway hypothesis and the spreading hypothesis of tau. Not only has the Apolipoprotein E (APOE) gene been shown to be associated with AD, but also with primary open angle glaucoma (POAG). This review will highlight the relevant literature in the past 20 years from PubMed that show the pathogenic overlap between POAG and AD. Neurodegenerative pathways that contribute to transsynaptic neurodegeneration in AD and other tauopathies might also be similar to those in glaucomatous neurodegeneration.
Bibliographic Details
http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85100557011&origin=inward; http://dx.doi.org/10.2147/eb.s293765; http://www.ncbi.nlm.nih.gov/pubmed/33500674; https://www.dovepress.com/glaucoma-as-neurodegeneration-in-the-brain-peer-reviewed-article-EB; https://dx.doi.org/10.2147/eb.s293765; https://www.dovepress.com/glaucoma-as-neurodegeneration-in-the-brain-peer-reviewed-fulltext-article-EB
Informa UK Limited
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know